XML 38 R27.htm IDEA: XBRL DOCUMENT v3.19.2
Restructuring and impairment charges (credits) (Tables)
6 Months Ended
Jun. 30, 2019
Restructuring and Related Activities [Abstract]  
Restructuring and Other Impairment Charges
The following tables provide information regarding restructuring and impairment charges recognized by the Company for the three and six months ended June 30, 2019 and July 1, 2018: 
Three Months Ended June 30, 2019
 
 
 
 
 
 
Termination benefits
 
Other costs (1)
 
Total
 
(Dollars in thousands)
2019 Footprint realignment plan
$
(459
)
 
$
30

 
$
(429
)
2018 Footprint realignment plan
(2,275
)
 
134

 
$
(2,141
)
Other restructuring programs (2)
62

 
312

 
374

Restructuring charges (credits)
(2,672
)
 
476

 
(2,196
)
Asset impairment charges

 
3,881

 
3,881

Restructuring and impairment charges (credits)
$
(2,672
)
 
$
4,357

 
$
1,685

Three Months Ended July 1, 2018
 
 
 
 
 
 
Termination benefits
 
Other costs (1)
 
Total
 
(Dollars in thousands)
2018 Footprint realignment plan
$
52,345

 
$
129

 
$
52,474

Other restructuring programs (4)
574

 
440

 
1,014

Restructuring charges
52,919

 
569

 
53,488

Asset impairment charges

 
1,865

 
1,865

Restructuring and impairment charges
$
52,919

 
$
2,434

 
$
55,353

Six Months Ended June 30, 2019
 
 
 
 
 
 
Termination Benefits
 
Other costs (1)
 
Total
 
(Dollars in thousands)
2019 Footprint realignment plan
$
12,516

 
$
30

 
$
12,546

2018 Footprint realignment plan
(1,838
)
 
708

 
(1,130
)
Other restructuring programs (2)
188

 
565

 
753

Restructuring charges
10,866

 
1,303

 
12,169

Asset impairment charges

 
6,911

 
6,911

Restructuring and impairment charges
$
10,866

 
$
8,214

 
$
19,080

Six Months Ended July 1, 2018
 
 
 
 
 
 
Termination Benefits
 
Other costs (1)
 
Total
 
(Dollars in thousands)
2018 Footprint realignment plan
$
52,345

 
$
129

 
$
52,474

2016 Footprint realignment plan (3)
2,199

 
291

 
2,490

Other restructuring programs (4)
1,032

 
555

 
1,587

Restructuring charges
55,576

 
975

 
56,551

Asset impairment charges

 
1,865

 
1,865

Restructuring and impairment charges
$
55,576

 
$
2,840

 
$
58,416

(1)
Other restructuring costs include facility closure, contract termination and other exit costs.
(2)
Includes the Vascular Solutions integration program (initiated in 2017) as well as the 2016 and 2014 Footprint realignment plans.
(3) The 2016 Footprint realignment plan involved the relocation of certain manufacturing operations, the relocation and outsourcing of certain distribution operations and a related workforce reduction at certain of the Company's facilities. The program is substantially complete and the Company expects future restructuring expenses associated with the program, if any, to be immaterial.
(4) Includes the 2014 Footprint realignment plan, the Vascular Solutions integration program and the EMEA restructuring program (initiated in 2017).
Summary Of Current Cost Estimates By Major Type Of Cost Table These actions are expected to be substantially completed during 2022. The following table provides a summary of the Company’s cost estimates by major type of expense associated with the 2019 Footprint realignment plan:
Type of expense
Total estimated amount expected to be incurred
Termination benefits
$19 million to $23 million
Other exit costs (1)
$1 million to $2 million
Restructuring charges
$20 million to $25 million
Restructuring related charges (2)
$36 million to $45 million
Total restructuring and restructuring related charges
$56 million to $70 million
(1)
Includes facility closure, employee relocation, equipment relocation and outplacement costs.
(2)
Restructuring related charges represent costs that are directly related to the 2019 Footprint realignment plan and principally constitute costs to transfer manufacturing operations to existing lower-cost locations, project management costs and accelerated depreciation. Most of these charges are expected to be recognized within cost of goods sold.